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Abstract
Aim Stoma reversal might lead to a stoma site incisional
hernia. Recently, prophylactic mesh reinforcement of the
stoma site has gained increased attention, supporting the
need for accurate data on the incidence of and risk factors
for stoma site incisional hernia and to identify high-risk
patients. The aim of this study was to assess incidence, risk
factors and prevention of stoma site incisional hernias.
Method Embase, MEDLINE, Web of Science,
Cochrane and Google Scholar databases were searched.
Studies reporting the incidence of stoma site incisional
hernia after stoma reversal were included. Study quality
was assessed with the Newcastle–Ottawa Scale and
Cochrane risk of bias tool. Data on incidence, risk factors
and prophylactic mesh reinforcement were extracted.
Results Of 1440 articles found, 33 studies comprising
4679 reversals were included. The overall incidence of
incisional hernia was 6.5% [range 0%–38%, median fol-
low-up 27.5 (17.54–36) months]. Eleven studies
assessed stoma site incisional hernia as the primary end-
point, showing an incidence of 17.7% [range 1.7%–
36.1%, median follow-up 28 (15.25–51.70) months].
Body mass index, diabetes and surgery for malignant
disease were found to be independent risk factors, as
derived from eight studies. Two retrospective compara-
tive cohort studies showed significantly lower rates of
stoma site incisional hernia with prophylactic mesh rein-
forcement compared with nonmesh controls [6.4% vs
36.1% (P = 0.001); 3% vs 19% (P = 0.04)].
Conclusion Stoma site incisional hernia should not be
underestimated as a long-term problem. Body mass
index, diabetes and malignancy seem to be potential risk
factors. Currently, limited data are available on the out-
comes of prophylactic mesh reinforcement to prevent
stoma site incisional hernia.
Keywords Stoma site incisional hernias, incidence, risk
factors, prevention
Introduction
Temporary stomas are frequently constructed to defunc-
tion a low colorectal anastomosis and during surgery
for acute complicated diverticulitis, inflammatory bowel
disease and traumatic intestinal injury [1–8]. Subse-
quent stoma reversal is associated with surgical site
infection (SSI), anastomotic leakage, postoperative ileus
and development of stoma site or midline incisional
hernia (MIH) [9–13]. Stoma site incisional hernia
(SSIH) can cause pain, disfiguration, incarceration and
strangulation [14,15].
Recent research has shown that prophylactic mesh
reinforcement (PMR) in midline laparotomies in high-
risk patients significantly decreases the incidence of
MIH [16,17], and PMR at the stoma site during per-
manent stoma construction has been considered to
reduce rates of parastomal hernia [18–21]. Considering
the largely comparable pathophysiology, PMR during
temporary ostomy takedown to prevent SSIH could also
be beneficial by potentially obviating complications and
re-operations, and has gained increased attention
amongst surgeons [17]. Accurate data on incidence and
risk factors for the development of SSIH are of impor-
tance to correctly assess the clinical value of PMR to
prevent SSIH, to facilitate selection of high-risk patients
and to aid clinical and shared decision-making [22].
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Therefore, the aims of this study were to systemati-
cally investigate the literature regarding the incidence of
SSIH after stoma reversal, to evaluate potential risk fac-
tors for SSIH and to assess the effectiveness of PMR in
preventing SSIH.
Method
The protocol of this study was registered in PROS-
PERO (CRD42016053347). This study was conducted
following the MOOSE guidelines and PRISMA state-
ment [23,24]. Furthermore, decisions on the content
were based on items proposed by Wille-Jørgensen
et al. [25].
Study design and participants
Randomized controlled trials (RCTs) and prospective or
retrospective cohort or case–control studies providing
data on the incidence of SSIH were included. Case
reports, reviews, letters, abstracts or comments were
excluded. Studies were included if they met the follow-
ing criteria: (1) patients ≥ 16 years of age, (2) partici-
pants underwent stoma reversal via laparotomy,
laparoscopy or local surgery, (3) study outcome
included data on the occurrence of SSIH and (4) fol-
low-up duration. Studies reporting on > 10% of patients
with abdominal wall trauma; only reporting on duo-
deno-/gastro-/oesophago- or urostomies; and only
including stoma revisions or re-siting were excluded.
Systematic literature search
A systematic search was performed by a biomedical
information specialist. On 4 July 2017, the Embase,
MEDLINE, Cochrane, Web of Science and Google
Scholar databases were searched. Full search syntaxes
and results per database are shown in Appendix S1 in
the online Supporting Information. There was no limit
on publication date. Identified articles were reviewed
independently by two reviewers (GS and DL) after
duplicates were removed on title and abstract, followed
by full-text review using EndNote X7. Differences in
article selection were discussed and inclusion or exclu-
sion was performed after consensus was reached
between reviewers.
Data extraction
Data extraction was performed by two researchers (GS
and DL) and checked by a third independent researcher
(RB). Discrepancies were discussed amongst all three
researchers, and decisions were made when consensus
was reached. In case of uncertainties on reported study
results, corresponding authors were contacted if possi-
ble. Two researchers (GS and DL) independently
assessed the quality of included studies by assessing level
of evidence [26], Newcastle–Ottawa Scale (NOS) crite-
ria (nonrandomized studies)[27] and risk of bias
(RCTs) [28].
Primary and secondary outcomes
The following outcome variables were extracted: study
characteristics (author, year, design, level of evidence,
risk of bias, NOS, SSIH detection methods), baseline
characteristics [number of patients, gender, age, body
mass index (BMI), smoking status, chemotherapy, sur-
gical type and approach, indication, follow-up dura-
tion], stoma characteristics [numbers constructed and
closed, stoma type (loop colostomy (LC) or ileostomy
(LI) and end colostomy (EC) or end ileostomy (EI)),
time to closure, closure method and surgical site
infection (SSI) after closure] and SSIH characteristics
(number of SSIH, SSIH per stoma type and SSIH
repairs). Median follow-up for reported cumulative
SSI and SSIH rates was calculated based on available
follow-up data.
Data synthesis
A Mantel–Haenszel random-effects model was used to
calculate pooled odds ratios (ORs), while taking
between-study variance and within-study variance into
account. ORs with 95% CIs were calculated to assess
outcome differences after ileostomy or colostomy
reversal. Q statistics and I2 were calculated to evaluate
heterogeneity. All analyses were performed with Rev-
Man 5.3 (Cochrane Centre, Denmark), except for the
cumulative meta-analysis, which was performed using
R (version 3.4.1.).
Results
Search
A PRISMA flow diagram of the full search results is
shown in Fig. 1. After fulfilling the search, a total of
2458 articles were identified, of which 1440 remained
after removal of duplicates. After screening on title and
abstract and full-text reading, 33 articles were included
for qualitative and quantitative analyses [3–8,29–55].
Four articles provided data on outcomes after PMR for
prevention of SSIH [45,46,56,57], of which two had a
nonmesh control group and could therefore be
included in quantitative synthesis [45,46].
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Study characteristics
Study characteristics are shown in Table 1. Two articles
were RCTs, 7 were prospective, 23 were retrospective
cohort studies and 1 study was case-matched. A total of
6594 nonmesh and 77 mesh patients were available.
The majority of studies (20/33) did not specify the
SSIH detection method. Two studies specifically men-
tioned the use of clinical examination and 11 reported
on imaging [ultrasound (US), CT or MRI].
Stoma characteristics
An overview of stoma characteristics is shown in
Table 2. Overall, 5289 stomas were constructed, of
which 4679 (88.5%) were closed. In three studies, the
type of colostomy or ileostomy was not clearly
described and was therefore reported as total number of
colostomies or ileostomies. In all other studies, LI was
the most investigated stoma type (28/30), followed by
LC (8/30), EC (6/30) and EI (5/30).
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Records after duplicates removed
(n = 1440)
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(n = 1440)
Full-text articles assessed
for eligibility
(n = 176)
Studies included in
qualitative synthesis
(n = 33)
Studies included in
quantitative synthesis
(n = 33)
Full-text articles excluded
(n = 141)
Non-English (2)
No data on incidence (38)
<16 years of age (18)
No mention of follow-up (27)
Abstract, letter, case series or
comment (41)
Full text not available (3)
Abdominal wall trauma (9)
Only data of midline hernia (3)
Records excluded
(n = 1266)
Additional records identified
through other sources
(n = 0)
Figure 1 Preferred items for reporting of systematic reviews and meta-analyses (PRISMA) flow diagram.
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Table 1 Study characteristics.
Author Year
Study details Patients
Design LOE NOS Number Male gender (%) Age (years) BMI (kg/m²) Smoking (%)
Bakx [29] 2004 R 2b 6 69 53.6 57 (28–83) – –
Bhangu [30] 2012 R 2b 6 59 76 62.7 (13.4) – –
Brook [5] 2016 R 2b 8 193 59.6 66 (20–92) 25 (16–44) 16
Cingi [31] 2008 P 2b 6 31 48.4 Hernia: 60.9 (11.0) Hernia: 30.1 (6.2) –
No hernia: 68 (14.3) No hernia: 26.2 (4.9)
De Keersm-
aecker [32]
2016 R 2b 6 153 60.1 67.1 (11.6) – –
D’Haeninck [33] 2011 R 2b 6 197 54.8 56.2 (15.4) 23.8 (3.8) –
Edwards [34] 2001 RCT* 1b – LC: 36 LC: 79.4 LC: 68 (32–90) – –
LI: 34 LI: 61.1 LI: 63 (40–85)
El-Hussuna [35] 2012 R 2b 5 159 67.3 65 (39–88) 24 (16.4–35.9) 17.6
Fiscon [36] 2014 P 2b 6 20 75 65.4 (53.1–72.1) 25.8 (23.9–28) –
Garcia-Botello [6] 2004 R 2b 6 127 57.5 54 (18.58) – –
Giannako-
poulos [7]
2009 R 2b 5 119 57.1 55 (39–66) 24.4 (22.3–26.8) –
Guzman-Valdivia [37] 2008 R 2b 6 70 59 61 (36–87) 36 (25–52) –
Hasegawa [38] 2000 RCT* 1b – 27 7.7 45.7 (23–76) – –
Holmgren [39] 2017 R 2b 8 316 56.7 67 (37–86) – –
K€ohler [40] 2014 R 2b 6 14 57.1 66 (43–86) 26.7 (20.4–31.8) –
Krand [41] 2008 P 2b 7 50 68 61 (23–78) – –
Lewis [42] 1990 P 2b 6 50 65 35 (17–71) – –
Li [43] 2017 R 2b 9 SSE: 139 SSE: 43.2 SSE: 40.7 (13.4) SSE: 25.5 (5.6) –
NSSE: 599 SSE: 57.8 NSSE: 42.8 (15.9) NSSE: 25.9 (5.9)
Liang [44] 2013 R 2b 6 No SSI: 82 No SSI: 94 No SSI: 64 (9.3) No SSI: 27 (6.3) –
SSI: 46 SSI: 95.6 SSI: 59 (10.9) SSI: 31 (6.1)
Liu [45] 2013 R 2b 9 Mesh: 47 Mesh: 63.8 Mesh: 69.6 (57.9–76.0) Mesh: 9 patients > 30 –
Control: 36 Control: 58.3 Control: 65.0 (57.8–70.5) Control: 12 patients
> 30
Luglio [8] 2011 P 2b 5 944 56.9 47.2 (16.8) 25.7 (5.2) –
Maggiori [46] 2015 CM 3b 9 Mesh: 30 Mesh: 60 Mesh: 61 (13, 25–79) Mesh: 26 (4, 19–36) –
Control: 64 Control: 62 Control: 61 (13, 28–84) Control: 25 (4, 18–
38)
Mala [47] 2008 R 2b 6 72 56 65 (39–89) – –
Mishra [48] 2014 R 2b 6 Lap: 289 Lap: 50.2 Lap: 68.2 (23.3) – –
Open: 768 Open: 59.4 Open: 68.5 (38.8)
Oriel [4] 2017 R 2b 6 114 Hernia: 100 – Hernia: 29.9 (5.9) Hernia: 54.6
No hernia: 96.1 No hernia: 27.5 (4.9) No hernia: 35.9
Rosen [49] 2005 R 2b 6 22 45.5 54 (33–73) 26 (19–34) –
Rutegard [50] 1987 R 2b 6 56 LC: 57.1 LC: 72 (38–94) – –
LI: 51.6 LI: 67 (26–89)
Saeed [51] 2012 P 2b 6 179 71.2 66 (29–79) – –
Saha [3] 2009 R 2b 6 325 53 59 (16–90) – –
Schrein-
emacher [52]
2011 P 2b 8 111 50.5 62 (18–84) < 25 (40.5); 25–29.9
(39.6); > 30 (19.8)
–
Seo [53] 2013 R 2b 6 836 66.7 56 (11) – –
Vermeulen [54] 2009 R 2b 6 HP: 139 HP: 55.6 HP: 61 (23–85) – –
PA: 19 PA: 84 PA: 63 (38–82)
Welten [55] 1991 R 2b 6 30 63.3 64.6 (56–84) – –
Continuous data are median (interquartile range), mean (standard deviation) or mean (standard deviation, range).
A, delayed closure group; B, early closure group; BMI, body mass index; C, clinical diagnosis; CM, case matched; CT, computed
tomography diagnosis; d, days; HP, Hartmann’s procedure; Lap, laparoscopic; LC, loop colostomy; LI, loop ileostomy; LOE, level
of evidence; m, months; MRI, magnetic resonance imaging; NOS, Newcastle–Ottawa scale; NSSE, nonstoma site extraction; P,
prospective; PA, primary anastomosis with diverting ileostomy; R, retrospective; RCT, randomized controlled trial; SSI, surgical site
infection; SSIH, stoma site incisional hernia; SSE, stoma site extraction; US, ultrasound; y, years.
*Data on risk of bias are given in Figure S1.
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Follow-up details
Method of closure
Method of SSIH
detectionChemo (%) Total duration Time to closure Time since closure
– – 24 w (2–124) 72 w (1–219) – –
– – 10 m (3–48) – C, CT or MRI
18.7 – 6 m (0.36) 20.5 m (0–69) Primary C, US, CT
– 26 m (3–118) 5.7 m (1–14) – Secondary C, US
– – 66 d (25–356) 2.56 y (1.62) – CT
– 34 m (1.9–64.2) 18.2 w (11.3–35.0) – Primary –
– – LC: 73 d (28–141) 36 m (6–48) Primary –
LI: 62 d (17–120)
– 95w (1–242) 18 w (8–137) – Primary –
– 44.1 m (23.5–58.8) 9.8 m (6.9–11.9) – Primary –
– – 9.1 m (18.6) 18.9 m (5.2) Primary –
– – 106d (69–174) > 2 m Primary –
– – – 28 m (2–87) Primary –
– 34 m (16–47) 4 m – Primary C
– 1331 d (34–2906) 272 d (55–1142) – – –
64.2 26 m (18–36) 10.4 d (8–14) – Primary –
– – A: 12 w (7–33) A: 27 m (4–50) Primary –
B: 12 d (10–14) B: 24 m (3–49)
– – 9 w (5–53) 0.5–2 y Primary –
2.7 SSE: 23.2 m (14.7–36.2) SSE: 4.7 m (3.0–9.0) SSE: 16.4 m (7.7–30.6) – –
NSSE: 32.7 m (18.5–48.6) NSSE: 5.4 (3.1–7.4) NSSE: 25.6 m (12.3–41.8)
– No SSI: 32 m (1–71) No SSI: 10 m (7.0) – No SSI: 49 open;
20 closed; 13 loose
C, CT
SSI: 30 m (2–73) SSI: 10 m (6.0) SSI: 19 open; 20 closed; 7 loose
Mesh: 51.1 18.2 m (11.7–30.8) Mesh: 9.2 m (4.1–15.0) – Mesh: onlay, skin defect open C, CT
Control: 30.6 Control: 8.6 m (4.1–15.1) Control: Skin defect open or closed
– – – 30d – –
– Mesh: 16.8 m
(3.3, 11.4–23.9)
Mesh: 11 w (5, 5–26) Mesh: 16.8 m (3.3, 11.4–23.9) Mesh: sublay, primary CT
Control: 39.2 m
(16.9, 14.9–79.7)
Control: 11 w (5, 2–27) Control: 39.2 m (16.9, 14.9–79.7) Control: primary
– – 4 m (1–11) 36 m (2–118) – –
– 44 m (9–72) 9 m (3–33) – – C, CT
– 5.7 y (0.5–14) Hernia: 245.1d (218.5) 5.7 y (0.5–14) – –
No hernia: 359.6d (707.4)
– 14.7 m 168d (69–385) 14.7 m – –
– 36–60 m – – – –
– 3 y 6 m (2–22) 1 y (n = 43), 2 y (n = 28),
3 y (n = 12)
– CT
15.7 67 m (12–96) 34 w (19–57) 67 m (12–96) – –
– 35 m (5–77) 6 m (1–48) 35 m (5–77) Primary = 99Se
condary = 12
C, US
– 54 m (6–146) 7 m (3) – – C, US, CT
– 18–150 m – – – C
– 25 m (6–52) 3.5 m (1–7) – – –
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Hernia rates
Table 3 provides data on the number of closures, SSIH, SSI
and SSIH repairs in individual studies for different stoma
types. The rate of SSI after stoma closure ranged from 0%
to 18.3% [median follow-up 28 (21.08–36) months]. SSIH
rates per stoma type are given in Table 4. The total SSIH
rate was 6.5%, with a range from 0% to 38.5% [median fol-
low-up 27.5 (17.54–36) months]. Eleven studies assessed
SSIH rate as the primary outcome, whereas the other stud-
ies recorded SSIH as a secondary outcome. The SSIH rate
of all 11 studies with SSIH rate as the primary outcome was
17.7% [172/970; range 1.7%–36.1%, median follow-up 28
(15.25–51.70) months]. Of these studies, nine used imag-
ing to detect hernias, also leading to a 17.7% rate (139/
786; range 1.7%–36.1%). From the 22 studies which did
not have SSIH as the primary outcome, an overall rate of
3.6% [129/3622; range 0%–38.5%, median follow-up 27
(16.56–36) months] was found. As calculated from 11
studies (11/33) that used imaging to detect hernias, the
SSIH rate was 15.3% [173/1134; range 1.2%–36.1%, med-
ian follow-up 28 (15.25–51.7) months]. In contrast, an
incidence rate of 3.7% for SSIH [128/3458; range 0%–
38.5%, median follow-up 27 (16.56–36) months] was
derived from all studies (22/31) that did not use or did not
mention the use of imaging for detection of SSIH.
Table 2 Stoma characteristics.
Author Year Stomas formed Stomas closed
Indications for stoma formation
CRC DIV IBD Trauma Other
Bakx [29] 2004 69 60 36 12 12 0 9
Bhangu [30] 2012 59 59 – – – – –
Brook [5] 2016 193 193 102 20 47 0 24
Cingi [31] 2008 31 31 23 4 – – –
De Keersmaecker [32] 2016 153 153 153 0 0 0 0
D’Haeninck [33] 2011 197 197 138 0 41 0 18
Edwards [34] 2001 70 63 70 0 0 0 0
El-Hussuna [35] 2012 159 158 159 0 0 0 0
Fiscon [36] 2014 20 20 3 12 0 0 5
Garcia-Botello [6] 2004 127 109 72 5 32 1 17
Giannakopoulos [7] 2009 119 119 49 10 33 2 25
Guzman-Valdivia [37] 2008 70 70 12 43 0 3 12
Hasegawa [38] 2000 13 13 0 0 0 0 13
Holmgren [39] 2017 273 229 273 0 0 0 0
K€ohler [40] 2014 14 14 10 4 0 0 0
Krand [41] 2008 50 50 46 0 2 0 2
Lewis [42] 1990 50 40 0 0 50 0 0
Li [43] 2017 SSE: 139 SSE: 139 SSE: 23 0 SSE: 106 0 SSE: 10
NSSE: 599 NSSE: 597 NSSE: 119 NSSE: 449 NSSE: 31
Liang [44] 2013 No SSI: 82 No SSI: 63 – – – – –
SSI: 46 SSI: 40
Liu [45] 2013 Mesh: 47 Mesh: 47 63 6 9 0 5
Control: 36 Control: 36
Luglio [8] 2011 944 944 279 64 507 0 94
Maggiori [46] 2015 Mesh: 30
Control: 64
Mesh: 30
Control: 64
Mesh: 30
Control: 64
0 0 0 0
Mala [47] 2008 72 62 72 0 0 0 0
Mishra [48] 2014 Lap: 35 Lap: 12 Lap: 35 0 0 0 0
Open: 282 Open: 68 Open: 282
Oriel [4] 2017 114 114 Hernia: 2 Hernia: 6 Hernia: 0 0 Hernia: 3
No hernia: 33 No hernia: 37 No hernia: 8 No hernia: 25
Rosen [49] 2005 22 22 2 15 0 1 4
Rutegard [50] 1987 61 23 19 15 3 0 19
Saeed [51] 2012 179 59 – – – – –
Saha [3] 2009 325 325 160 25 118 0 22
Schreinemacher [52] 2011 111 111 53 0 33 0 25
Seo [53] 2013 246 245 246 0 0 0 0
Vermeulen [54] 2009 HP: 139 HP: 63 0 HP: 139 0 0 0
PA: 19 PA: 14 PA: 19
Welten [55] 1991 30 23 – – – – –
C, colostomy; CRC, colorectal carcinoma; DIV, diverticular disease; EC, end colostomy; EI, end ileostomy; IBD, inflammatory
bowel disease; HP, Hartmann’s procedure; Lap, laparoscopic; LC, loop colostomy; LI, loop ileostomy; NSSE, nonstoma site
extraction; PA, primary anastomosis with diverting ileostomy; SSI, surgical site infection; SSE, stoma site extraction.
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Figure 2 shows a forest plot of seven studies from
which data could be used to compare SSIH rates after
ileostomy and colostomy reversal. No difference in
SSIH risk was found (OR 0.82, 95%CI 0.40–1.69, I2
0%). Publication bias seemed unlikely, because the study
distribution was justifiably symmetrical in an additional
funnel plot (Fig. 3). In addition, no differences were
found in cumulative meta-analysis (cumulative OR
0.87, 95%CI 0.44–1.75), as shown in Figure S2.
SSIH operation rates
SSIH operation data are shown in Table S1. No data
on SSIH operations were available for LC and EI. Of
all patients undergoing stoma closure, 6.1% (0%–38.4%)
needed an operation for SSIH. Of the patients with
SSIH, 51.4% (0%–100%) were operated. In the total
ileostomy group, these percentages were 5.6% (0%–
12.5%) and 56.4% (0%–100%), respectively, as derived
from 10 studies.
Risk factors
Eight studies reported on risk factors for development of
SSIH (Table S2) [3–5,30–32,45,52]. In univariate analy-
sis, Brook et al. [5] found a significantly higher BMI in
patients who developed SSIH compared with patients
without SSIH (mean 28.4 kg/m² vs 24.7 kg/m²).
Primary surgery Stoma types
Acute Elective Lap Open LC LI EC EI C (total) I (total)
– – – – 0 69 0 0 0 69
– – – – 0 49 10 0 10 49
23 169 50 139 0 193 0 0 0 193
– – 0 31 8 4 16 3 24 7
0 153 53 100 0 153 0 0 0 153
– – – – 0 197 0 0 0 197
– 70 – – 36 34 0 0 36 34
0 159 0 159 0 158 0 0 0 158
– – 3 17 0 0 20 0 20 0
– 118 – – 0 127 0 0 0 127
– – – 23 0 119 0 0 0 119
– – – – – – – – 65 5
– – – – 12 1 0 0 12 1
– – – – 38 235 0 0 38 235
– – 4 10 0 14 0 0 0 14
0 50 – – 0 50 0 0 0 50
0 50 – – 0 50 0 0 0 50
– – – – 0 SSE: 51 0 SSE: 88 0 SSE: 139
NSSE: 286 NSSE: 313 NSSE: 599
No SSI: 45 No SSI: 37 No SSI: 19 No SSI: 63 No SSI: 7 No SSI: 41 No SSI: 18 No SSI: 16 No SSI: 25 No SSI: 57
SSI: 34 SSI: 12 SSI: 16 SSI: 30 SSI: 5 SSI: 13 SSI: 21 SSI: 7 SSI: 26 SSI: 20
– – 46 37 0 Mesh: 47 0 0 0 Mesh: 47
Control: 36 Control: 36
– 944 – – 0 944 0 0 0 944
0 Mesh: 30
Control: 64
Mesh: 30
Control: 64
0 0 Mesh: 30
Control: 64
0 0 0 Mesh: 30
Control: 64
– – – – 10 61 0 1 10 62
– – 289 768 – – – – Lap: 16 Lap: 19
Open: 135 Open: 147
Hernia: 0 Hernia: 11 – – – – – – Hernia: 5 Hernia: 6
No hernia: 2 No hernia: 101 No hernia: 47 No hernia: 56
– – 20 2 0 0 22 0 22 0
40 21 – – 29 32 0 0 29 32
– – – – 0 92 0 87 0 179
55 270 – – 0 325 0 0 0 325
– – – – 64 47 0 0 64 47
0 836 – – 0 246 0 0 246 0
HP: 139 0 – – 0 19 139 0 139 19
PA: 19
24 6 – – 0 30 0 0 30 0
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Moreover, they found a significantly higher percentage of
clinically obese patients (BMI ≥ 30 kg/m²) in the SSIH
group (42.3% vs 15%, P < 0.001). From a logistic regres-
sion model, an OR of 1.2 was found for BMI. Further-
more, from a nonparametric correlation test of Stage 1
hypertension (≥ 140/90 mmHg), a Spearman’s rho of
0.183 was found (P = 0.01). In addition, malignant
disease was found to be associated with a higher likeli-
hood of hernia in logistic regression analysis (OR 18,
P = 0.009) and, albeit in univariate analysis, postopera-
tive complication rates were higher in patients with SSIH
(27% vs 22%, P < 0.001).
Liu et al. [45] investigated the influence of PMR
versus no mesh in ileostomy closures and assessed
Table 3 Hernia rates (subdivided per study).
Author Year
All stomas
SSIH per stoma type
Number of
stoma
closures
Number of
SSIH (%)
Number of
SSI (%)
LC LI EC
Closed SSIH (%) Closed SSIH (%) Cl
Bakx [29] 2004 60 5 (8.3) 4 (6.7) 0 0 60 5 (8.3) 0
Bhangu [30] 2012 59 20 (33.9) – 0 0 49 16 (32.7) 10
Brook [5] 2016 193 26 (13.8) – 0 0 193 26 (13.8) 0
Cingi [31] 2008 31 10 (32.3) 4 (12.9) 8 3 (37.5) 4 2 (50) 16
De Keersmaecker
[32]
2016 153 17 (11.1) – 0 0 153 17 (11.1) 0
D’Haeninck [33] 2011 197 7 (3.6) 9 (4.6) 0 0 197 7 (3.6) 0
Edwards [34] 2001 63 5 (7.9) LC: 2 (6.5)
LI: 1 (3.1)
31 5 (16.1) 32 0 0
El-Hussuna [35] 2012 158 8 (5.1) 8 (5.1) 0 0 158 8 (5.1) 0
Fiscon [36] 2014 20 3 (15) 0 0 0 0 0 20
Garcia-Botello [6] 2004 109 13 (11.9) 20 (18.3) 0 0 109 13 (11.9) 0
Giannakopoulos
[7]
2009 119 2 (1.7) 12 (10.1) 0 0 119 2 (1.7) 0
Guzman-Valdivia
[37]
2008 70 22 (31.4) 3 (4.3) – – – – –
Hasegawa [38] 2000 13 5 (38.5) 1 (7.6) 12 – 1 – 0
Holmgren [39] 2017 229 1 (0.4) – 34 – 195 – 0
K€ohler [40] 2014 14 4 (28.6) 0 0 0 14 4 (28.6) 0
Krand [41] 2008 50 1 (2) 4 (8) 0 0 50 1 (2) 0
Lewis [42] 1990 40 0 1 (2.5) 0 0 40 0 0
Li [43] 2017 SSE: 139 SSE: 2 (1.4) SSE: 4 (2.8) 0 0 SSE: 51 – 0
NSSE: 597 NSSE: 11 (1.8) NSSE: 20 (3.4) NSSE: 286
Liang [44] 2013 No SSI: 63* No SSI: 15 (23.8) 46 No SSI: 7 – No SSI: 41 – No
SSI: 40* SSI: 16 (40) SSI: 5 SSI: 13 SS
Liu [45] 2013 Mesh: 47 Mesh: 3 (6.4) Mesh: 2 (4.3) 0 0 Mesh: 47 Mesh: 3 (6.4) 0
Control: 36 Control: 13 (36.1) Control: 1 (2.8) Control: 36 Control: 13 (36.1)
Luglio [8] 2011 944 1 (0.1) 44 (4.7) 0 0 944 1 (0.1) 0
Maggiori [46] 2015 Mesh: 30 Mesh: 1 (3.3) Mesh: 2 (6.7) 0 0 Mesh: 30 Mesh: 1 (3.3) 0
Control: 64 Control: 12 (18.8) Control: 1 (1.6) Control: 64 Control: 12 (18.8)
Mala [47] 2008 62 5 (8.1) 2 (3.2) – – – – –
Mishra [48] 2014 Lap: 12 Lap: 1 (8.3) – – – – – –
Open: 68 Open: 3 (4.4) – – – – – –
Oriel [4] 2017 114 11 (9.7) – – – – – –
Rosen [49] 2005 22 1 (4.5) 3 (13.6) 0 0 0 0 22
Rutegard [50] 1987 23 1 (4.3) – 15 1 (6.7) 8 0 0
Saeed [51] 2012 59 1 (1.7) – 0 0 92 – 0
Saha [3] 2009 325 18 (5.5) 24 (7.4) 0 0 325 18 (5.5) 0
Schreinemacher
[52]
2011 111 36 (32.4) 12 (10.8) 64 – 47 – 0
Seo [53] 2013 245 3 (1.2) 0 0 0 245 3 (1.2) 0
Vermeulen [54] 2009 HP: 63 HP: 0 HP: 7 (11.1) 0 0 14 1 (7.1) 63
PA: 14 PA: 1 (7.1) PA: 1 (7.1)
Welten [55] 1991 23 1 (4.3) 2 (8.7) 0 0 23 1 (4.3) 0
C, colostomy; EC, end colostomy; EI, end ileostomy; HP, Hartmann’s procedure; Lap, laparoscopic; LC, loop colostomy; LI, loop
ileostomy; NSSE, nonstoma site extraction; PA, primary anastomosis with diverting ileostomy; SSI, surgical site infection; SSIH,
stoma site incisional hernia; SSE, stoma site extraction.
*Late outcomes of stoma closures were available in 63 of 92 no SSI patients and 40 out of 46 SSI patients.
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potential risk factors. From univariate analyses, the fol-
lowing significant factors were found: age > 60 years,
malignant disease, diabetes, hypertension, chronic ster-
oid usage and chronic kidney injury. A multivariate
analysis was performed and showed malignancy (OR
21.93, 95% CI 1.58–303.95, P = 0.02) and diabetes
(OR 20.98, 95% CI 3.23–136.31, P = 0.001) to be
independent risk factors for SSIH.
Bhangu et al. [30] found no significant differences in
age or gender for patients with SSIH versus no SSIH.
Moreover, no difference in MIH between patients with
and without SSIH was found (50% vs 41%, P = 0.51).
Age, SSI, stoma type, gender, BMI and time to closure
did not significantly increase the risk of SSIH in the study
by Cingi et al. [31]. However, patients with a MIH had
an increased risk (OR 4.4) of SSIH.
SSIH repair
EC EI C (total) I (total)
Closed SSIH (%) Closed SSIH (%) Closed SSIH (%) Closed SSIH (%)
0 0 0 0 0 0 60 5 (8.3) –
10 4 (40) 0 0 10 4 (40) 49 16 (32.7) 4
0 0 0 0 0 0 193 26 (13.8) 19
16 5 (31.3) 3 0 24 8 (33.3) 7 2 (28.6) 3
0 0 0 0 0 0 153 17 (11.1) 6
0 0 0 0 0 0 197 7 (3.6) 7
0 0 0 0 31 5 (16.1) 32 0 –
0 0 0 0 0 0 158 8 (5.1) –
20 3 (15) 0 0 20 3 (15) 0 0 3
0 0 0 0 0 0 109 13 (11.9) 8
0 0 0 0 0 0 119 2 (1.7) –
– – – – 65 21 (32.3) 5 1 (20) –
0 0 0 0 12 – 1 – 5
0 0 0 0 34 – 195 – –
0 0 0 0 0 0 14 4 (28.6) –
0 0 0 0 0 0 50 1 (2) 0
0 0 0 0 0 0 40 0 0
0 0 SSE: 88 – 0 0 SSE: 139 SSE: 2 (1.4) –
NSSE: 313 NSSE: 597 NSSE: 11 (1.8)
No SSI: 18 – No SSI: 16 – No SSI: 25 – No SSI: 57 – –
SSI: 21 SSI: 7 SSI: 26 SSI: 20 –
0 0 0 0 0 0 Mesh: 47 Mesh: 3 (6.4) Mesh: 0
Control: 36 Control: 13 (36.1) Control: 3
0 0 0 0 0 0 944 1 (0.1) –
0 0 0 0 0 0 Mesh: 30 Mesh: 1 (3.3) Mesh: 0
Control: 64 Control: 12 (18.8) Control 8
– – – – – 1 – 4 3
– – – – – – Lap: 12 1 Lap: 1
– – – – – – Open: 68 3 Open: 1
– – – – 52 5 (9.6) 56 6 (10.7) –
22 1 (4.5) 0 0 22 1 (4.5) 0 0 0
0 0 0 0 15 1 (6.7) 8 0 –
0 0 – – 0 0 59 1 (1.7) –
0 0 0 0 0 0 325 18 (5.5) –
0 0 0 0 64 – 47 – –
0 0 0 0 0 0 245 3 (1.2) –
63 0 0 0 63 0 14 1 (7.1) –
0 0 0 0 0 0 23 1 (4.3) 0
D. P. V. Lambrichts et al. Review of stoma site incisional hernias
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De Keersmaecker et al. [32] assessed a number of
potential patient- and surgery-related risk factors but
did not find any significant differences in univariate
analysis.
Oriel et al. [4] showed that myofascial release was
performed more often in the SSIH group (18.2% vs
2.9%, P = 0.02) and more SSIH patients had superficial
incisional SSI (27.3% vs 5.8%, P = 0.01).
From univariate analyses, Saha et al. [3] found the
development of SSIH to be significantly associated with
reoperation after LI reversal (3% vs 25%, P < 0.001)
and emergency surgery (4% vs 13%, P = 0.01).
Lastly, Schreinemacher et al. [52] performed a multi-
variate analysis for risk factors, which only showed that
BMI (≥ 30 kg/m2 vs < 25 kg/m2) was a significant
risk factor (OR 5.53, 95% CI 1.72–17.80), whereas a
time to closure of < 6 months did not appear as risk
factor (OR 2.38, 95% CI 0.96–5.99, P = 0.06).
Prophylactic mesh reinforcement
Four studies provided data on PMR outcomes, of which
details are given in Table 5. Bhangu et al. [56] used
biological mesh (StratticeTM) and intraperitoneal onlay
mesh (IPOM) placement in a case series of seven
patients. During 30-day follow-up, only one adverse
event was seen (a SSI with subsequent superficial
wound breakdown) while the mesh was still in situ (on
US).
In the case series by Van Barneveld et al. [57], 10
patients received a Parietex Composite Parastomal
mesh during creation of a temporary stoma for paras-
tomal hernia prophylaxis (IPOM placement). At stoma
reversal, mesh continuity was restored to serve as SSIH
prophylaxis. No serious mesh-related or other serious
complications were observed during 12 month’ follow-
up. After a median follow-up of 26 months [interquar-
tile range (IQR) 14–29), no SSIH was found during
physical and US examination in nine patients.
Two other studies, by Liu et al. and Maggiori et al.,
were comparative cohort studies, including 83 and 94
patients, respectively [45,46]. In the retrospective study
by Liu et al. [45], consecutive patients undergoing
ileostomy closure were included, of whom 47 (56.6%)
had PMR with polypropylene mesh (Ultrapro, Ethicon
Inc.) placed in an onlay position by the same surgeon
in all patients. During median follow-up of
18.2 months (IQR 11.7–30.8), three SSIHs (6.4%)
were detected in mesh patients, whereas 13 SSIHs
(36.1%) were found in control patients (OR 8.29, 95%
CI 2.14–32.08, P = 0.001). SSIH in the mesh group
was small and asymptomatic, and did not require repair,
compared with 23% SSIH repairs in control patients. In
the matched case–control study by Maggiori et al. [46],
30 consecutive patients were individually matched to
patients from a prospective database. In these patients, a
biological mesh (noncross-linked collagen, porcine der-
mal matrix; Meccellis BioTech, France) was placed in a
retromuscular position. At 1-year CT follow-up, SSIH
incidence was lower in mesh patients than the control
group (3% vs 19%, P = 0.04), while postoperative mor-
bidity was similar in both groups (17% vs 11%,
P = 0.51). SSIH repair was needed in eight control
patients (13% vs 0%, P = 0.05).
Discussion
This study shows an overall incidence of SSIH of 6.5%
[range 0%–38.5%, median follow-up 27.5 (17.54–36)
months], which is in accordance with the review by
Table 4 Hernia rates (subdivided by stoma type).
Stoma group Studies
Number of
stomas
closed
Number of
SSIH
detected
Percentage
SSIH
detected (%) Range (%)*
Median
follow-up (IQR)†
Loop colostomy 3 54 9 16.7 6.7–37.5 36 (36–36)
Loop ileostomy 21 2837 150 5.3 0–50 23.75 (14.92–43.75)
End colostomy 4 131 13 9.9 0–40 12.35 (10–12.35)
End ileostomy 1 3 0 0 – –
Colostomy 9 302 48 15.9 0–40 28 (12.35–52.20)
Ileostomy 26 3776 175 4.6 0–36.1 27 (18.53–51.50)
Total 33 4602 301 6.5 0–38.5 27.5 (17.54–36)
Only control patients were included, patients with prophylactic mesh placement were excluded.
SSIH, stoma site incisional hernia; IQR, interquartile range.
*Range of SSIH percentages reported in studies.
†Median (IQR) of available information on reported median study follow-up since closure (months).
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Bhangu et al. [58], who reported an overall hernia rate
of 7% (range 0%–48%, median follow-up 36 months).
However, this study was based on a smaller number of
patients (n = 2698) than the present study (n = 4602).
Both previous studies, by Bhangu et al. and Nguyen
et al., reported on significant heterogeneity between
studies and difficulties in interpretation and combining
study results [58,59]. To reduce this heterogeneity, sev-
eral inclusion and exclusion criteria were used during
our systematic literature search (Fig. 1). Most impor-
tantly, to be included, studies had to mention follow-up
duration, since hernia rates increase over time and
might vary between different durations. Furthermore,
studies with > 10% of patients with abdominal trauma
were excluded, as earlier reports showed these patients
to be more prone to hernia development [60,61].
To compare the SSIH rate between ileostomy and
colostomy reversal, seven studies were eligible for analy-
sis. Whereas the previous review of Bhangu et al. [58]
showed a significantly different lower SSIH rate after
ileostomy (OR 0.28, 95% CI 0.12–0.65), this review
found no significant difference in the risk of SSIH
between ileostomy and colostomy (OR 0.82, 95% CI
0.40–1.69), which was also not found in an additional
cumulative meta-analysis (cumulative OR 0.87, 95% CI
0.44–1.75).
In this study, only one-third (11/33) of included
studies assessed SSIH incidence as the primary out-
come. Twenty studies did not mention detection meth-
ods and, therefore, it seems likely to assume that
imaging was not used in these studies. To investigate
potential underestimation, the overall incidence of SSIH
from the 11 studies with SSIH as the primary outcome
was calculated (17.7%, range 1.7%–36.1%) [4,5,30–
32,37,45,46,48,51,52]. These rates indeed support the
hypothesis that the overall incidence of hernia from all
included studies (6.5%), as from those only reporting
on SSIH as a secondary outcome (3.6%), is an underes-
timation. The potential risk of underestimation by not
using imaging for detection of SSIH is further sup-
ported by the higher incidence in studies that used
imaging, compared with studies that did not use, or did
not mention the use of imaging as a detection method
(15.3% vs 3.7%, respectively). Indeed, from the litera-
ture on incisional hernias it is known that prevalence
rates vary substantially, through differences in diagnostic
modalities, observer, definition and diagnostic protocol
[62]. The use of imaging, which led to higher SSIH
rates, might have identified asymptomatic or occult her-
nias. Therefore, the overall SSIH rate of 6.5% seems to
be lower but more clinically relevant, and thus it
remains debatable if PMR might even be necessary at
all. Hence, it is important to identify high-risk patients,
in whom PMR might still be of added value and if in
these patients its risks outweigh its benefits.
Eight studies were identified that reported on poten-
tial risk factors for development of SSIH. Three studies
[5,45,52] performed a multivariate analysis, from which
BMI, primary surgery for malignant disease and diabetes
mellitus were identified as potential risk factors. BMI is
known to affect midline incisional and parastomal hernia
rates [16,63–66], which might be explained by higher
intra-abdominal pressure and consequent higher
Study or Subgroup Events
IIeostomy Colostomy Odds Ratio
EventsTotal Total Weight M-H, Random, 95% CI
Odds Ratio
M-H, Random, 95% CI
Bhangu (2012)
Cingi (2008)
Edwards (2001)
Oriel (2017)
Rustegard (1987)
Vermeulen (2009)
Total (95% CI)
Total events
0.02 0.1
Favours ileostomy Favours colostomy
1 10 50Heterogeneity: τ
2
 = 0.01; χ2 = 6.08, df = 6 (P = 0.41; I2 = 1%)
Test for overall effect: Z = 0.54 (P = 0.59)
Guzman-Valdivia (2008)
16
2
0
6
0
1
171 260
26 44
1
49
7
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56
8
14
5
4
8
5
5
1
0
21
10 0.73 [0.18, 2.95]
0.80 [0.13, 5.07]
0.07 [0.00, 1.40]
0.52 [0.06, 4.98]
1.13 [0.32, 3.94]
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0.82 [0.40, 1.69]
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Figure 2 Forest plot of SSIH rates. M-H, random, Mantel–Haenszel random-effects model; df, degrees of freedom.
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Figure 3 Funnel plot of the included studies
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abdominal wall tension [16,67]. Additionally, obesity
and diabetes are associated with wound healing compli-
cations due to local hypoxia, caused by a decreased vas-
cularization of adipose tissue and other microvascular
changes, impairing collagen synthesis and having a neg-
ative effect on the overall healing process [16,68].
Smoking has a comparable negative effect on wound
healing and is considered a risk factor for incisional her-
nia [69]. However, none of the included studies has
shown a significant effect on occurrence of SSIH. More-
over, with regard to primary surgery for malignant dis-
ease, factors as malnutrition, poor general health and
immunosuppressive effects of chemotherapy are thought
to negatively affect the normal healing process
[45,68,70]. Wound infections are known to increase
the risk of hernia formation [63,71]; however, in the
present literature review SSIs were not found to be
independently associated with an increased risk of SSIH.
Overall, the study by Oriel et al. [4] was the only study
to identify superficial SSI as a factor contributing to
future SSIH formation. The data on risk factors in this
review might help with the selection of high-risk
patients and therefore help guide clinical decision-mak-
ing, potentially involving PMR. Moreover, since factors
such as obesity and smoking can potentially be mini-
mized, it might be of interest to focus not only on
PMR but also on lifestyle interventions such as preoper-
ative weight loss, smoking cessation and nutritional
optimization for the prevention of SSIHs. However, to
date no evidence is available on the efficacy or effective-
ness of these lifestyle interventions with regard to inci-
dence of SSIH.
Four studies reported on PMR for SSIH prevention
[45,46,56,57]. These studies had several methodological
limitations that made it difficult to draw conclusions
about the potential added value of PMR. Two of the
studies reported on a very limited number of patients
(n < 10), decreasing their generalizability [56,57]. Fur-
thermore, these studies had no control (nonmesh)
group. Two other studies on PMR were of better quality
because they included larger numbers of patients and as
well as control patients [45,46]. Liu et al. [45] stated
that mesh placement significantly reduced the incidence
of SSIH following ileostomy closure, without an increase
in complications. Maggiori et al. [46] reported a signifi-
cant difference in SSIH on 1-year follow-up CT in
favour of PMR. Nevertheless, all four studies recognized
the need for RCTs to further evaluate the beneficial
Table 5 Overview of studies reporting on prophylactic mesh placement for the prevention of SSIH.
Author Year Design
Mesh or
control
Method of closure
Control
group
Outcome
measure
SSIH
detection
methodMesh type
Mesh
placement
Bhangu
[56]
2014 CS Mesh Biological
(StratticeTM)
IPOM None 30-day
outcomes
–
Liu [45] 2013 R Mesh Polypropylene
(Ethicon
Ultrapro)
Onlay – Rate of
SSIH
C and/or
CT
Control – – Skin defect
open
Maggiori
[46]
2015 CM Mesh Bioprosthetic,
noncross-linked
collagen,
porcine dermal
matrix (Meccellis,
Biotech)
Sublay,
retromuscular
– 1-year rate
of SSIH
CT
Control – – Primary
closure
van
Barneveld
[57]
2013 CS Mesh ParietexTM
Composite
Parastomal
mesh +
AbsorbaTackTM
(Covidien/
Medtronic)
IPOM None SSIH and
mesh
complications
C and
US
Continuous data are mean (standard deviation), mean (standard deviation, range), or median (interquartile range).
C, clinical diagnosis; CT, computed tomography diagnosis; CS, case series; EI, end ileostomy; LC, loop colostomy; LI,
loop ileostomy; m, months; R, retrospective; CM, case matched; IPOM, intraperitoneal onlay mesh; SSI, surgical
site infection; SSIH, stoma site incisional hernia; US, ultrasound.
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effects, safety and (cost-) effectiveness of PMR. Efforts
have already been made by several research groups, and
further trial results are awaited. A feasibility study by the
Reinforcement of Closure of Stoma Site (ROCSS) Col-
laborative has recently been published and reported their
study protocol to be feasible, without early safety concerns
[72]. Based on their data, progression towards their
ROCCS trial (ClinicalTrials.gov identifier NCT02238964)
has continued [72,73]. Several other trials have been initi-
ated, such as the MEMBO trial (NCT02576184), the
ILEOCLOSE trial (NCT02226887) and the LISTO-trial
(NCT02669992). Next to ileostomy closure, only the
ROCCS trial also includes patients undergoing colostomy
closure, and none of these trials focuses on a specific
risk group, such as obese patients. However, since obe-
sity seems to increase the risk of SSIH after stoma clo-
sure, this group of patients might potentially benefit
more from PMR, although, paradoxically, these
patients, especially in case of diabetes, might at the
same time also be at higher risk of developing mesh-
related complications [74,75]. Therefore, it would be
interesting to see the results of PMR in these patients
specifically. With regard to the efficacy and (cost-)
effectiveness of PMR, it is still debatable as to what
would be a clinically significant reduction in SSIH rates.
In the case of the ROCCS trial, sample size calculation
of the full Phase III study was based on a 40% reduc-
tion (25% to 15%) in the 2-year clinical hernia rate
[72]. In the study by Maggiori et al. [46], a 16% differ-
ence was found (19% vs 3%, P = 0.043), which might
have been used for the sample size calculation of the
MEMBO trial. However, further data on sample size
calculations and risk reduction were not available.
Unfortunately, robust conclusions cannot yet be drawn
on its risks and benefits from the available literature on
PMR. If PMR is proven to be beneficial in these
studies, further implications for practice should be
made sufficiently clear (e.g. patient selection) in
order to overcome the barriers of implementing these
findings [76].
The low level of evidence and the vast heterogeneity
of the included studies are two important limitations of
this study. Nevertheless, inclusion of these studies was
still deemed necessary as they allowed a more compre-
hensive overview of potential risk factors, as well as
more detailed analyses of SSIH and repair rates. The
Patients Follow-up details
Number of
stomas
closed
Type
of
stomas
Number
of
SSIH (%)
Number
of
SSI (%)Number
Male
gender
(%) Age BMI (kg/m²) Total
Time to
closure
Time
since
closure
7 – – – 30 days – 30 days 7 LI, EI 0 1 (14.3)
47 63.8 69.6
(57.9–76.0)
> 30, n = 9 18.2 m
(11.7–30.8)
9.2 m
(4.1–15.0)
– 47 LI 3 (6.4) 2 (4.3)
36 58.3 65.0
(57.8–70.5)
> 30, n = 12 18.2 m
(11.7–30.8)
8.6 m
(4.1–15.1)
– 36 LI 13 (36.1) 1 (2.8)
30 60 61
(13, 25–79)
26 (4, 19–36) 16.8 m
(3.3, 11.4–23.9)
11 weeks
(5, 5–26)
30 LI 1 (3.3) 2 (6.7)
64 62 61
(13, 28–84)
25 (4, 18–38) 39.2 m
(16.9, 14.9–79.7)
11 weeks
(5, 2–27)
64 LI 12 (18.8) 1 (1.5)
10 40 66 (58–77) 25 (20–28) – 6 m (2–15) 10 LI, LC 0 1 (10)
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lack of a predefined time period from which studies
could be included might also have been a limitation of
this review, because important changes in operative and
perioperative care of patients have been introduced in
recent decades (e.g. laparoscopy). However, this effect
is presumably largely negligible since the majority of
included studies were published in the previous decade
(Table 1).
In conclusion, this review shows an overall incidence
of SSIH of 6.5% (range 0%–38.5%), as well as an inci-
dence of 17.7% (range 1.7%–36.1%) from 11 studies
assessing SSIH as the primary outcome. Furthermore,
potential risk factors have been identified, of which
BMI, malignant disease and diabetes were considered to
be the most important. Lastly, early results from four
studies on PMR were identified, but no robust conclu-
sions could be drawn. Results of ongoing trials are
awaited.
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